437 related articles for article (PubMed ID: 32402912)
21. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
22. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
23. Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor-β.
Shao W; Li X; Peng J; Fan S; Liang M; Huang K
J Cell Mol Med; 2020 Sep; 24(17):10128-10139. PubMed ID: 32697395
[TBL] [Abstract][Full Text] [Related]
24. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
[TBL] [Abstract][Full Text] [Related]
25. Kanglexin counters vascular smooth muscle cell dedifferentiation and associated arteriosclerosis through inhibiting PDGFR.
Yang S; Zhao Y; Cao S; Liu X; Feng M; Chen Y; Ma C; Zhan T; Zhang Q; Jia H; Zhao Y; Tong M; Yu Y; Liu X; Yang B; Zhang Y
Phytomedicine; 2024 Jul; 130():155704. PubMed ID: 38759316
[TBL] [Abstract][Full Text] [Related]
26. Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice.
Zhu L; Hao Y; Guan H; Cui C; Tian S; Yang D; Wang X; Zhang S; Wang L; Jiang H
Mol Cell Biochem; 2013 Jan; 373(1-2):53-62. PubMed ID: 23065380
[TBL] [Abstract][Full Text] [Related]
27. AKAP1 alleviates VSMC phenotypic modulation and neointima formation by inhibiting Drp1-dependent mitochondrial fission.
Sun J; Shao Y; Pei L; Zhu Q; Yu X; Yao W
Biomed Pharmacother; 2024 Jul; 176():116858. PubMed ID: 38850669
[TBL] [Abstract][Full Text] [Related]
28. Critical role of histone demethylase Jumonji domain-containing protein 3 in the regulation of neointima formation following vascular injury.
Luo X; Yang D; Wu W; Long F; Xiao C; Qin M; Law BY; Suguro R; Xu X; Qu L; Liu X; Zhu YZ
Cardiovasc Res; 2018 Dec; 114(14):1894-1906. PubMed ID: 29982434
[TBL] [Abstract][Full Text] [Related]
29. Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid artery.
Ishii S; Okamoto Y; Katsumata H; Egawa S; Yamanaka D; Fukushima M; Minami S
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):359-66. PubMed ID: 23324994
[TBL] [Abstract][Full Text] [Related]
30. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
[TBL] [Abstract][Full Text] [Related]
31. MYBPH inhibits vascular smooth muscle cell migration and attenuates neointimal hyperplasia in a rat carotid balloon-injury model.
Zhu T; He Y; Yang J; Fu W; Xu X; Si Y
Exp Cell Res; 2017 Oct; 359(1):154-162. PubMed ID: 28800959
[TBL] [Abstract][Full Text] [Related]
32. Semaphorin-3A protects against neointimal hyperplasia after vascular injury.
Wu JH; Zhou YF; Hong CD; Chen AQ; Luo Y; Mao L; Xia YP; He QW; Jin HJ; Huang M; Li YN; Hu B
EBioMedicine; 2019 Jan; 39():95-108. PubMed ID: 30579864
[TBL] [Abstract][Full Text] [Related]
33. The herbal extract HMC05 inhibits neointima formation in balloon-injured rat carotid arteries: possible therapeutic implications of HMC05.
Lee JW; Lee BS; Lee JY; Ku HJ; Jeon SR; Kim JY; Ban JM; Sung SH; Shin HM; Park JE
J Ethnopharmacol; 2011 Jan; 133(1):168-76. PubMed ID: 20883768
[TBL] [Abstract][Full Text] [Related]
34. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
[TBL] [Abstract][Full Text] [Related]
35. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
[TBL] [Abstract][Full Text] [Related]
37. The effect of 2,3,4',5-tetrahydroxystilbene-2-0-β-D glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms.
Xu XL; Ling DY; Zhu QY; Fan WJ; Zhang W
Eur J Pharmacol; 2013 Jan; 698(1-3):370-8. PubMed ID: 23178522
[TBL] [Abstract][Full Text] [Related]
38. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.
Yan G; Wang Q; Hu S; Wang D; Qiao Y; Ma G; Tang C; Gu Y
Int J Mol Med; 2015 Oct; 36(4):1001-11. PubMed ID: 26311435
[TBL] [Abstract][Full Text] [Related]
39. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury.
Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B
Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423
[TBL] [Abstract][Full Text] [Related]
40. Hydrogen-rich saline attenuates vascular smooth muscle cell proliferation and neointimal hyperplasia by inhibiting reactive oxygen species production and inactivating the Ras-ERK1/2-MEK1/2 and Akt pathways.
Chen Y; Jiang J; Miao H; Chen X; Sun X; Li Y
Int J Mol Med; 2013 Mar; 31(3):597-606. PubMed ID: 23340693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
